“Yiqi Huayu, Wenyang Lishui” Prescription (YHWLP) Improves the Symptoms of Chronic Obstructive Pulmonary Disease-Induced Chronic Pulmonary Heart Disease by Inhibiting the RhoA/ROCK Signaling Pathway

Table 4

Comparison of decreases in PT, aPTT, Fbg, and D-dimer (relative to baseline) between the two groups.

Group	PT (s)	aPTT (s)	Fbg (g/L)	D-D (mg/L)
YHWLP (n = 40)	2.96 ± 1.72	4.25 ± 2.44	2.67 ± 1.61	3.08 ± 1.52
Control (n = 40)	1.45 ± 0.58	2.12 ± 0.64	1.28 ± 0.36	1.53 ± 1.69

Notes: PT, prothrombin time; aPTT, activated partial thromboplastin time; Fbg, fibrinogen; D-D, D-dimer. Values are mean ± standard deviation. , .